SCHEMBL13611553

SCHEMBL13611553

CC1=CCC(C(N)=O)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259769 0.72 — —
SCHEMBL20145978 0.71 — —
SCHEMBL1628554 0.67 NNMT (0.31) —
Carbamic Acid SCHEMBL15321134 0.64 — —
SCHEMBL15109012 0.62 TSHR (0.36) —
SCHEMBL8333628 0.62 — —
SCHEMBL3653697 0.61 GABRR1 (0.35) —
SCHEMBL23158237 0.59 — —
SCHEMBL7137241 0.59 — —
SCHEMBL6053567 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286798-A1 FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-11-19 — — US disclosed
Send feedback